None of the Six SNPs of IL28B Could Predict Treatment Responses in Genotype 2 Chronic HCV Infected Patients by Propensity Score Matching Analysis

BACKGROUND & AIMS: A combination of pegylated interferon-alpha and ribavirin (PR) is the standard therapy for patients with chronic hepatitis C. The impact of polymorphism of interleukin-28B (IL28B) on sustained virological response (SVR) to PR has been well documented in patients with CHC genot...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeng, Wen-Juei, Lin, Chun-Yen, Chen, Ji-Yih, Huang, Chang-Wen, Huang, Chien-Hao, Sheen, I-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500244/
https://www.ncbi.nlm.nih.gov/pubmed/23173032
http://dx.doi.org/10.1371/journal.pone.0048217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500244/
https://www.ncbi.nlm.nih.gov/pubmed/23173032
http://dx.doi.org/10.1371/journal.pone.0048217

Ejemplares similares